-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 UogWdcXsQrIpffJmOJXEgC/9598jg5wbQjWeoIpqmuMEkWkGSzuvZC0cZznSytB1
 e4CA//473ahtaS3TCJCUcg==

<SEC-DOCUMENT>0001169232-04-006125.txt : 20041220
<SEC-HEADER>0001169232-04-006125.hdr.sgml : 20041220
<ACCEPTANCE-DATETIME>20041220152521
ACCESSION NUMBER:		0001169232-04-006125
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20041217
ITEM INFORMATION:		Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20041220
DATE AS OF CHANGE:		20041220

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EZ EM INC
		CENTRAL INDEX KEY:			0000727008
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				111999504
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0529

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-100878
		FILM NUMBER:		041213996

	BUSINESS ADDRESS:	
		STREET 1:		717 MAIN ST
		CITY:			WESTBURY
		STATE:			NY
		ZIP:			11590
		BUSINESS PHONE:		5163338230
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d61624_8-k.txt
<DESCRIPTION>FORM 8-K
<TEXT>

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                              Washington, DC 20549

                          ----------------------------

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant To Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

       Date of Report (date of earliest event reported): December 17, 2004
                                                         -----------------

                                  E-Z-EM, INC.
             ------------------------------------------------------
             (Exact Name of Registrant as Specified in its Charter)

                                    Delaware
                 ----------------------------------------------
                 (State or Other Jurisdiction of Incorporation)

                   1-11479                              11-1999504
         ------------------------           ---------------------------------
         (Commission File Number)           (IRS Employer Identification No.)

1111 Marcus Avenue, Lake Success, New York                 11042
- ------------------------------------------               ---------
  (Address of Principal Executive Offices)               (Zip Code)

                                 (516) 333-8230
              ----------------------------------------------------
              (Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions.

|_|   Written communications pursuant to Rule 425 under the Securities Act (17
      CFR 230.425)

|_|   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)

|_|   Pre-commencement communications pursuant to Rule 14d-2(b) under the
      Exchange Act (17 CFR 240.14d-2(b))

|_|   Pre-commencement communications pursuant to Rule 13e-4(c) under the
      Exchange Act (17 CFR 240.13e-4(c))

<PAGE>

ITEM 5.02   Departure of Directors or Principal Officers; Election of Directors;
            Appointment of Principal Officers

            (b) On December 17, 2004, Dr. Michael A. Davis resigned as a Class I
            director of E-Z-EM, Inc. (the "Company") effective December 31,
            2004. On December 20, 2004, the Company issued a press release
            announcing Dr. Davis's resignation, a copy of which is attached as
            Exhibit 99.1 and incorporated herein by reference.

Item 9.01  Financial Statements and Exhibits

            (c)   Exhibits

                  99.1  Press release dated December 20, 2004.


                                       2
<PAGE>

                                   SIGNATURES:

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Dated: December 20,2004                     E-Z-EM, INC.
                                            (Registrant)


                                            By: /s/ Anthony A. Lombardo
                                                --------------------------------
                                                Anthony A. Lombardo


                                       3
<PAGE>

EXHIBIT INDEX
- -------------

Exhibit No.              Description
- -----------              -----------

99.1                     Press Release dated December 20, 2004


                                       4

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d61624_ex99-1.txt
<DESCRIPTION>PRESS RELEASE
<TEXT>

                                                                    Exhibit 99.1

           [LOGO] E-Z-EM(TM)
- ----------------------------
Visualize a healthier world.

Company Contacts:                     Investor Relations Contacts:
E-Z-EM, Inc.                          Lippert/Heilshorn & Associates, Inc.
- ------------                          ------------------------------------
Tom Johnson (tjohnson@ezem.com)       Kim Sutton Golodetz (kgolodetz@lhai.com)
             -----------------                             ------------------
(800) 544-4624 x3317                  (212) 838-3777
www.ezem.com                          Bruce Voss (bvoss@lhai.com)
- ------------                                      --------------
                                      (310) 691-7100

FOR IMMEDIATE RELEASE

                            E-Z-EM BOARD OF DIRECTORS
                  ACCEPTS RESIGNATION FROM DR. MICHAEL A. DAVIS

LAKE SUCCESS, N.Y., December 20, 2004--E-Z-EM, Inc., (AMEX: EZM) today announced
that its Board of Directors has accepted the previously planned resignation of
Michael A. Davis, MD, DSc. Dr. Davis' intention to resign was previously
disclosed in the Company's proxy statement dated October 21, 2003, and the Board
is actively seeking a successor. This resignation is part the program
implemented over recent years to enhance the Board's independence as well as to
gain new expertise and perspective. Dr. Davis will continue to serve the Company
in his capacity as Medical Director.

Howard S. Stern, Chairman of the E-Z-EM Board, said "Mike Davis has provided
valued leadership and commitment to the growth of the Company, and we are
extremely pleased that his considerable knowledge and insight will still be
available to us. On behalf of the entire E-Z-EM family, I thank Dr. Davis for
his years of service as a member of our Board."

About E-Z-EM, Inc.

E-Z-EM is a leading manufacturer of contrast agents for gastrointestinal
radiology. The Company has developed the only CT injector on the market that can
help detect contrast extravasation, the EmpowerCT(R) with patented EDA(TM)
technology; it also offers a complete product set for the virtual colonoscopy
practitioner. This product line consists of virtual colonoscopy hardware,
software, nutritional prep kits and bowel cleaners, tagging agents and a carbon
dioxide colon insufflation system.

                                      # # #

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
